Characterization of Dermal Fibroblasts as a Cell Source for Pediatric Tissue Engineered Heart Valves

• Main Authors: Monica M. Fahrenholtz, Huiwen Liu, Debra L. Kearney, Lalita Wadhwa, Charles D. Fraser, K. Jane Grande-Allen
• Format: Article
• Language: English
• Published: MDPI AG 2014-08-01
• Series: Journal of Cardiovascular Development and Disease
• Subjects: fibroblasts; pediatric; valvular interstitial cell; VIC; TEHV; extracellular matrix; substrate
• Online Access: http://www.mdpi.com/2308-3425/1/2/146

There is continued debate regarding the appropriate cell type to replace valvular interstitial cells (VICs) in tissue engineered heart valves (TEHVs), particularly for pediatric patients. In this work, neonatal human dermal fibroblasts (nhDFFs) were compared to human pediatric VICs (hpVICs), based on their phenotypic and gene expression characteristics when cultured on collagen type I, fibronectin, fibrin, and tissue culture polystyrene (TCP) substrates. Similar confluency was achieved over the culture period on collagen and fibronectin between both cell types, although nhDFFs tended to reach lower confluence on collagen than on any other substrate. Morphologically, hpVICs tended to spread and form multiple extensions, while nhDFFs remained homogenously spindle-shaped on all substrates. PCR results indicated that fibroblasts did not differ significantly from VICs in gene expression when cultured on fibrin, whereas on collagen type I and fibronectin they showed increased α-SMA, xylosyltransferase I, and collagen type I expression (p < 0.05). However, protein expression of these targets, analyzed by immunocytochemistry and Western blotting, was not significantly different between cell types. These results suggest that nhDFFs express similar matrix production and remodeling genes as hpVICs, and the choice of substrate for TEHV construction can affect the growth and expression profile of nhDFFs as compared to native hpVICs.